• In late July 2026, Synopsys announced expanded AI-powered EDA collaborations with Intel Foundry, Microsoft, AMD, and NVIDIA, alongside new autonomous agentic workflows for chip and system design spanning implementation, verification, and thermal analysis.
• These moves highlight Synopsys’ attempt to embed agentic AI across the silicon-to-systems workflow, potentially deepening its role in next-generation AI infrastructure design.
• We’ll now examine how Synopsys’ push into autonomous agentic AI workflows could influence the existing investment narrative around Ansys integration.

Uncover the next big thing with 21 elite penny stocks that balance risk and reward.

Synopsys Investment Narrative Recap

To own Synopsys, you need to believe it can turn its silicon to systems platform, including Ansys, into a durable, high margin growth engine despite recent earnings volatility and a premium valuation. The latest AI EDA collaborations reinforce that story, but do not appear to materially change the near term execution risk around integrating Ansys, managing higher costs, and delivering on margin recovery targets after restructuring.

The new autonomous, agentic CAE workflow for electronics thermal analysis with NVIDIA, built on Ansys Icepak, directly ties Synopsys’ AI push to the Ansys integration catalyst. By embedding Ansys multiphysics into long running AI driven flows, Synopsys is starting to show how its combined portfolio can support more complex, multi die and system level designs, which is central to the wider silicon to systems thesis many investors are watching.

However, investors should also be aware that the Ansys integration, combined with higher debt and restructuring costs, could...

Synopsys' narrative projects $12.5 billion revenue and $2.0 billion earnings by 2029. This requires 12.8% yearly revenue growth and about a $1.2 billion earnings increase from $773.3 million today.

Uncover how Synopsys' forecasts yield a $559.58 fair value, a 43% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community currently see Synopsys’ fair value between US$512.02 and US$559.58, compared with a market price near US$392. With that spread of views, you should weigh the AI and Ansys driven growth story against the risk that higher integration costs and restructuring could pressure margins and complicate execution over the next few years.

Explore 3 other fair value estimates on Synopsys - why the stock might be worth as much as 43% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Synopsys research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Synopsys research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Synopsys' overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Explore 25 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Find 53 companies with promising cash flow potential yet trading below their fair value.
• We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.